The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member
The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| Aimmune | Lecture fee | B |
| Nestle | Lecture fee | B |
| Sanofi | Lecture fee, advisory committee | C |
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| Infectopharm | Clinical trial fees | B |
| ALK Albello | Clinical Trial fees | B |
| Nestle | Unrestricted grant, investigator initiated research | D |
| Sanofi | Clinical trial fees | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
| Company | Area | Product | Amount of funds received* |
|---|---|---|---|
| Boehringer Ingelheim | ILD | Nintedanib | B |
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| Boehringer Ingelheim | Advisory/Lectures | B |
| MSD | Advisory/Lectures | B |
| AstraZeneca | Advisory/Lectures | B |
| GSK | Advisory/Lectures | B |
| Sanofi | Advisory/Lectures | B |
| Pfizer | Advisory/Lectures | B |
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| Fitbit | Unrestricted grant | D |
| Novo Nordisk | Unrestricted grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| MSD | lectures | B |
| Pfizer | lectures; advisory committee | B |
| AstraZeneca | lectures; advisory committee | B |
| Takeda | lectures; | B |
| Amgen | lectures; | B |
| Adamed | lectures; | B |
| Grifols | lectures; | B |
| CSL Behring | lectures;advisory committee | B |
| Mereo Biopharma | advisory committee | B |
| Company | Purpose and Nature of Benefit | Amount of funds received* |
|---|---|---|
| MSD | conference | B |
| Amgen | conference | B |
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| Biocartis | donated to my Institution | A |
| Pfizer | donated to my Institution | B |
| AstraZeneca | reserach grant donated to my Institution | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| AZ | Member of advisory board | B |
| Chiesi | Speaker | A |
| Chiesi | Chapter writer | A |
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| AZ | Research project on COVID | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
| Company | Area | Product | Amount of funds received* |
|---|---|---|---|
| Philips | Chronic Ventilatory Support | ventilator | B |
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| TEVA pharmaceuticals | Honorarium for a non-promotional talk in a sponsored symposium at the ERS 2022 | B |
| Sandoz pharmaceuticals | Honorarium for a non-promotional talk in a sponsored symposium at the PCRS 2022 | B |
| Boehringer-Ingelheim | Honorarium for a non-promotional talk in the UK Respiratory Academy 2020 | B |
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| AstraZeneca | Ad board, consultancy | B |
| GSK | Ad board, consultancy, steering committee | C |
| Chiesi | Ad board, consultancy, presentation | C |
| Biosency | consultancy | A |
| Menarini | presentation | B |
| Sanofi | ad board | C |
| NOvartis | Ad board | B |
| Zambon | presentation | B |
| Teva | ad board | A |
| Pfizer | ad board | A |
| MSD | presentation | A |
| ALK | presentation | B |
| Company | Purpose and Nature of Benefit | Amount of funds received* |
|---|---|---|
| Chiesi | CPLF | A |
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| GSK | research | D |
| Pfizer | research | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| DFG | Research grant | D |
| Umwelt- und Nachbarschaftshaus | Research grant | D |
| Umweltbundesamt | Research grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Dimitris is a cystic fibrosis patient and advocate as well as Vice President of the Greek Patient Association, and founder of Patients Hub.
He won the European Lung Foundation (ELF) Award in 2021 for his efforts to ensure equal access to innovative treatments and health services for all.
None
| Company | Purpose of Payment | Amount of funds received* |
|---|---|---|
| Roche; Boeringher-inghelheim; ERBE | occasional consultancy | A |
| Company | Purpose and Nature of Benefit | Amount of funds received* |
|---|---|---|
| Boehringer-Ingelheim | travel grants | B |
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| Astra Zeneca; Roche; Boehringer-inghelheim; ERBE; PulmoniX | speaker's fees, research support | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
All ERS Assembly Heads are also members of the Executive Committee.